Dr. Plews arrives with a background in biotechnology and medical aesthetics, a combination CEO John Oakley believes will sharpen the company’s physician education and scientific communication efforts. The firm, a subsidiary of KNOW Bio, LLC, centers its business on patented light therapies designed to stimulate natural biological processes. Plews intends to prioritize the translation of complex biological data into measurable clinical outcomes, distancing the company’s output from pure marketing rhetoric.

His immediate agenda includes upcoming appearances at The Aesthetic Show in late June 2026. He is slated to lead a CME session on regenerative aesthetics and participate in a panel focused on innovations in hair restoration. These engagements mirror his ongoing work as an educator in the longevity and aesthetics sectors, where he frequently discusses the application of exosomes and secretomes in modern treatment protocols.